Factors associated with coverage of cotrimoxazole prophylaxis in HIV-exposed children in South Africa.

PLoS One

Womens Health and HIV Research Unit, Department of Obstetrics and Gynaecology, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.

Published: December 2013

AI Article Synopsis

  • The study investigated the administration of cotrimoxazole (CTX) prophylaxis in HIV-exposed infants in a South African primary health clinic, following WHO recommendations.
  • One-third of these infants had not started CTX, with breastfeeding infants showing higher initiation rates compared to non-breastfed infants.
  • Maternal understanding of CTX was low, with many mothers not administering the correct dosage, which contributed to inconsistent CTX coverage among HIV-exposed infants.

Article Abstract

Background: The World Health Organisation and the Joint United Nations Programme in 2006 reaffirmed the earlier recommendation of 2000 that all HIV-exposed infants in resource-poor countries should commence cotrimoxazole (CTX) prophylaxis at 6-weeks of life. CTX prophylaxis should be continued until the child is confirmed HIV-uninfected and there is no further exposure to breastmilk transmission. We determined CTX coverage and explored factors associated with CTX administration in HIV-exposed infants at a primary health clinic in South Africa.

Methods: In a cross-sectional study of HIV-exposed infants 6-18 months of age attending a child immunisation clinic, data from the current visit and previous visits related to CTX prophylaxis, feeding practice and infant HIV testing were extracted from the child's immunisation record. Further information related to the administration of CTX prophylaxis was obtained from an interview with the child's mother.

Results: One-third (33.0%) HIV-exposed infants had not initiated CTX at all and breastfed infants were more likely to have commenced CTX prophylaxis as compared to their non-breastfed counterparts (78.7% vs 63.4%) (p = 0.008). Availability of infant's HIV status was strongly associated with continuation or discontinuation of CTX after 6 months of age or after breastfeeding cessation. Maternal self-reports indicated that only 52.5% (95%CI 47.5-57.5) understood the reason for CTX prophylaxis, 126 (47%) did not dose during weekends; 55 (21%) dosed their infants 3 times a day and 70 (26%) dosed their infants twice daily.

Conclusion: A third of HIV-exposed children attending a primary health care facility in this South African setting did not receive CTX prophylaxis. Not commencing CTX prophylaxis was strongly associated with infants not breastfeeding and unnecessary continued exposure to CTX in this paediatric population was due to limited availability of early infant diagnosis. Attendance at immunization clinics can be seen as missed opportunities for early infant diagnosis of HIV and related care.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646768PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063273PLOS

Publication Analysis

Top Keywords

ctx prophylaxis
32
hiv-exposed infants
16
ctx
13
prophylaxis
9
factors associated
8
hiv-exposed children
8
infants
8
primary health
8
months age
8
dosed infants
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!